INGHIRAMI, Giorgio

INGHIRAMI, Giorgio  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 219 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation 2005 PENG W ;ZHANG X ;MOHAMED N ;INGHIRAMI G ;TAKESHITA K ;PECORA A ;NARDONE LL ;PINCUS SE ;CASEY LS ;SPITALNY GL
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 2015 Abate, F.; Todaro, M.; Van Der Krogt, J.-A.; Boi, M.; Landra, I.; Machiorlatti, R.; Tabbò, F.; Messana, K.; Abele, C.; Barreca, A.; Novero, D.; Gaudiano, M.; Aliberti, S.; Di Giacomo, F.; Tousseyn, T.; Lasorsa, E.; Crescenzo, R.; Bessone, L.; Ficarra, E.; Acquaviva, A.; Rinaldi, A.; Ponzoni, M.; Longo, D.L.; Aime, S.; Cheng, M.; Ruggeri, B.; Piccaluga, P.P.; Pileri, S.; Tiacci, E.; Falini, B.; Pera-Gresely, B.; Cerchietti, L.; Iqbal, J.; Chan, W.C.; Shultz, L.D.; Kwee, I.; Piva, R.; Wlodarska, I.; Rabadan, R.; Bertoni, F.; Inghirami, G.
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 2006 PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G
Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. 1988 Inghirami G; Simon J; Balow JE; Tsokos GC.
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 2016 Serra, Sara; Vaisitti, Tiziana; Audrito, Valentina; Bologna, Cinzia; Buonincontri, Roberta; Chen, Shih-Shih; Arruga, Francesca; Brusa, Davide; Coscia, Marta; Jaksic, Ozren; Inghirami, Giorgio; Rossi, Davide; Furman, Richard R.; Robson, Simon C.; Gaidano, Gianluca; Chiorazzi, Nicholas; Deaglio, Silvia
ALK protein tyrosine kinase, cells and methods embodying and using same 2005 R. Chiarle; G. Inghirami
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 2012 Tabbó F; Barreca A; Piva R; Inghirami G; The European T-Cell Lymphoma Study Group (;Riccardo Bruna; Daniele Corino; Diego Cortese; Ramona Crescenzo; Giuditta Cuccuru; Filomena di Giacomo; Alessandro Fioravanti; Marco Ladetto; Indira Landra; Katia Messana; Rodolfo Machiorlatti; Barbara Martinoglio; Enzo Medico; Marta Mossino; Elisa Pellegrino; Maria Todaro; Paola Campisi; Luigi Chiusa; Annalisa Chiappella; Domenico Novero; Umberto Vitolo; Francesco Abate; Andrea Acquaviva; Elisa Ficarra; Roberto Freilone; Marco Chilosi; Alberto Zamó; Fabio Facchetti; Silvia Lonardi; Anna De Chiara; Franco Fulciniti; Claudio Doglioni; Maurilio Ponzoni; Luca Agnelli; Antonino Neri; Katia Todoerti; Claudio Agostinelli; Pier Paolo Piccaluga; Stefano Pileri; Brunangelo Falini; Enrico Tiacci; Peter Van Loo; Thomas Tousseyn; Christiane De Wolf-Peeters; Eva Geissinger; Hans Konrad Muller-Hermelink; Andreas Rosenwald; Miguel Angel Piris; Maria E. Rodriguez; Francesco Bertoni; Michela Boi; Ivo Kwee;)
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. 2002 XU R ;PERLE MA ;INGHIRAMI G ;CHAN W ;DELGADO Y ;FEINER H
Analysis of the activating Kras mutations in advanced colorectal tumors: a three-year diagnostic experience 2011 Mariani, S.; Francia di celle, P.; Di Bello, C.; Bonello, L.; Toppino, D.; Tondat, F.; Barreca, A.; Molinaro, L.; Cassoni, P.; Chiusa, L.; Sapino, A.; Inghirami, G.
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 2009 Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Anaplastic large-cell lymphoma 2011 Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME.
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 2002 ZAMO A; R. CHIARLE; PIVA R; HOWES J; FAN Y; CHILOSI M; LEVY DE; INGHIRAMI G.
Anaplastic lymphoma kinase in human cancer 2011 Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G; European T-Cell Lymphoma Study Group;(Barreca A; Chiarle R; Cuccuru G; Inghirami G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Voena C; Fornari A; Novero D; Chilosi M; Zamò A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Piccaluga PP; Pileri S; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Konrad Muller-Hermelink H; Rosenwald A; Piris MA; Rodriguez ME)
Anaplastic Lymphoma Kinase is an effective oncoantigen for lymphoma vaccination 2007 R. Chiarle; G. Inghirami; G. Forni
Anaplastic lymphoma kinase: an oncogene for tumor vaccination 2009 Mastini C; Martinengo C; Inghirami G; Chiarle R.
Anaplastic lymphoma Kinase: molecular mechanisms of lymphoid transformation 2006 Inghirami
Anti-Hu-associated peripheral nerve and muscle microvasculitis. 1993 Younger DS; Dalmau J; Inghirami G; Sherman WH; Hays AP.
Association of low P27 with loss of hormone receptors in small (T1a/b) breast cancers 2006 Wu J; Mirchandani D; Smith, JA; Inghirami G; Roses D; Zeleniuch-Jacquotte A; Muggia F
Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including Ig VH gene and CD5 antigen expression 1991 Inghirami G; Foitl DR; Sabichi A; Zhu BY; Knowles DM.
Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including Ig VH gene and CD5 antigen expression. 1991 G. INGHIRAMI; FOITL DR; SABICHI A; ZHU BY; KNOWLES DM